Focus: Kestra Medical Technologies is a public medical device company headquartered in Kirkland, WA, specializing in wearable cardiovascular devices with applications across cardiovascular, metabolic, neurology, and gastroenterology segments. The company operates as a focused player in the wearable medical technology space with a public market presence.
Profile data last refreshed 16h ago · AI intelligence enriched 1mo ago
Hot — 133 jobs added in 30d
Net +133 (133 new, 0 removed). Aggressive expansion phase.
Kestra offers innovative wearable device work and strong culture, but the severe cash position, lack of hiring, and pre-clinical pipeline create substantial execution risk for near-term job seekers.
Help build intelligence for Kestra Medical Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Kestra Medical Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488 - Stock Titan
Kestra Medical (KMTS) CBO adds 227 ESPP shares, now holds 42,488 Stock Titan
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14 - GlobeNewswire
Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14 GlobeNewswire
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE) The Globe and Mail
Laurexa Capital closes €520M fundraising to propel European medtech - Mugglehead Investment Magazine
Laurexa Capital closes €520M fundraising to propel European medtech Mugglehead Investment Magazine
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares - The Motley Fool
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares The Motley Fool
Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB) The Globe and Mail
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo